Hematology TimesFDA approves drug to treat relapsed FLSeptember 15, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesImmune status linked to outcomes of CAR T-cell therapySeptember 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesReport details progress, obstacles in cancer research and careSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated IssuesAMLALL
Hematology NewsBiosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesBiosimilar deemed equivalent to reference drug in FLSeptember 12, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesCCSs have higher burden of chronic conditionsSeptember 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA places full, partial holds on durvalumab trialsSeptember 8, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesNanocarriers could treat leukemia, lymphoma and improve HSCTSeptember 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas
Hematology TimesCNS lymphoma responds to CAR T-cell therapyAugust 30, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrug receives priority review for FLAugust 29, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesHigh healthcare costs follow CCSs into adulthoodAugust 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrug granted orphan designation for chemo-induced ototoxicityAugust 23, 2017Lymphoma & Plasma Cell DisordersPediatricsPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesAntibody could treat AML, MM, and NHLAugust 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeObinutuzumab-CHOP not superior to rituximab-CHOP in new DLBCLAugust 17, 2017Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Oncology PracticeCrizotinib shows responses in pediatric ALCL and IMTAugust 15, 2017Lymphoma & Plasma Cell DisordersPediatricsAggressive Lymphomas
